Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Slco4c1 | Rat | (-)-demecolcine | decreases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Demecolcine results in decreased expression of SLCO4C1 mRNA | CTD | PMID:23649840 | Slco4c1 | Rat | 1,1-dichloroethene | decreases expression | ISO | Slco4c1 (Mus musculus) | 6480464 | vinylidene chloride results in decreased expression of SLCO4C1 mRNA | CTD | PMID:26682919 | Slco4c1 | Rat | 1,2-dichloroethane | decreases expression | ISO | Slco4c1 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of SLCO4C1 mRNA | CTD | PMID:28960355 | Slco4c1 | Rat | 17beta-estradiol | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Estradiol results in increased expression of SLCO4C1 mRNA | CTD | PMID:21185374 | Slco4c1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Slco4c1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLCO4C1 mRNA | CTD | PMID:19770486 | Slco4c1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLCO4C1 mRNA | CTD | PMID:20106945|PMID:21632981|PMID:21998131 | Slco4c1 | Rat | 2-palmitoylglycerol | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of SLCO4C1 mRNA | CTD | PMID:37199045 | Slco4c1 | Rat | 3-iodothyronamine | affects uptake | ISO | SLCO4C1 (Homo sapiens) | 6480464 | SLCO4C1 mRNA affects the uptake of 3-iodothyronamine | CTD | PMID:19074582 | Slco4c1 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of more ... | CTD | PMID:16997883 | Slco4c1 | Rat | 8-Br-cAMP | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of more ... | CTD | PMID:16997883 | Slco4c1 | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of SLCO4C1 mRNA | CTD | PMID:28959563 | Slco4c1 | Rat | aflatoxin B1 | affects expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of SLCO4C1 protein | CTD | PMID:20106945 | Slco4c1 | Rat | aflatoxin B1 | increases methylation | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of SLCO4C1 intron | CTD | PMID:30157460 | Slco4c1 | Rat | aflatoxin B1 | decreases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of SLCO4C1 mRNA | CTD | PMID:21632981|PMID:21641981|PMID:27153756 | Slco4c1 | Rat | all-trans-retinoic acid | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of SLCO4C1 mRNA | CTD | PMID:21934132|PMID:33167477 | Slco4c1 | Rat | allopurinol | decreases expression | EXP | | 6480464 | Allopurinol results in decreased expression of SLCO4C1 mRNA | CTD | PMID:37876353 | Slco4c1 | Rat | amiodarone | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Amiodarone results in increased expression of SLCO4C1 mRNA | CTD | PMID:19774075 | Slco4c1 | Rat | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of SLCO4C1 mRNA | CTD | PMID:30779732 | Slco4c1 | Rat | aristolochic acid A | decreases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of SLCO4C1 mRNA | CTD | PMID:33212167 | Slco4c1 | Rat | atenolol | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Atenolol results in increased expression of SLCO4C1 mRNA | CTD | PMID:19915711 | Slco4c1 | Rat | azathioprine | decreases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Azathioprine results in decreased expression of SLCO4C1 mRNA | CTD | PMID:22623647 | Slco4c1 | Rat | belinostat | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | belinostat results in increased expression of SLCO4C1 mRNA | CTD | PMID:26272509 | Slco4c1 | Rat | belinostat | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Slco4c1 | Rat | benzo[a]pyrene | decreases expression | ISO | Slco4c1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of SLCO4C1 mRNA | CTD | PMID:19770486|PMID:21715664 | Slco4c1 | Rat | benzo[a]pyrene | increases methylation | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of SLCO4C1 exon | CTD | PMID:27901495 | Slco4c1 | Rat | benzo[a]pyrene | affects methylation | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of SLCO4C1 3' UTR; Benzo(a)pyrene affects the methylation of SLCO4C1 promoter | CTD | PMID:27901495 | Slco4c1 | Rat | benzo[a]pyrene | decreases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of SLCO4C1 mRNA | CTD | PMID:20064835|PMID:20106945|PMID:21632981|PMID:26238291|PMID:32234424|PMID:38036013 | Slco4c1 | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SLCO4C1 mRNA | CTD | PMID:26238291 | Slco4c1 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SLCO4C1 mRNA | CTD | PMID:25181051 | Slco4c1 | Rat | butanal | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of SLCO4C1 mRNA | CTD | PMID:26079696 | Slco4c1 | Rat | cadmium atom | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLCO4C1 more ... | CTD | PMID:35301059 | Slco4c1 | Rat | cadmium dichloride | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLCO4C1 more ... | CTD | PMID:35301059 | Slco4c1 | Rat | caffeine | increases phosphorylation | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Caffeine results in increased phosphorylation of SLCO4C1 protein | CTD | PMID:35688186 | Slco4c1 | Rat | carbon nanotube | affects expression | ISO | Slco4c1 (Mus musculus) | 6480464 | Nanotubes, Carbon affects the expression of SLCO4C1 mRNA | CTD | PMID:25554681 | Slco4c1 | Rat | carbon nanotube | increases expression | ISO | Slco4c1 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in increased expression of SLCO4C1 mRNA | CTD | PMID:25554681 | Slco4c1 | Rat | chloroprene | decreases expression | ISO | Slco4c1 (Mus musculus) | 6480464 | Chloroprene results in decreased expression of SLCO4C1 mRNA | CTD | PMID:23125180 | Slco4c1 | Rat | cyclosporin A | increases expression | ISO | Slco4c1 (Mus musculus) | 6480464 | Cyclosporine results in increased expression of SLCO4C1 mRNA | CTD | PMID:19770486|PMID:25270620 | Slco4c1 | Rat | cyclosporin A | decreases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of SLCO4C1 mRNA | CTD | PMID:20106945|PMID:24907557|PMID:25562108 | Slco4c1 | Rat | dexamethasone | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of more ... | CTD | PMID:16997883 | Slco4c1 | Rat | Dibutyl phosphate | affects expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of SLCO4C1 mRNA | CTD | PMID:37042841 | Slco4c1 | Rat | dicrotophos | decreases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of SLCO4C1 mRNA | CTD | PMID:28302478 | Slco4c1 | Rat | dorsomorphin | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Slco4c1 | Rat | doxorubicin | affects expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Doxorubicin affects the expression of SLCO4C1 mRNA | CTD | PMID:25529476 | Slco4c1 | Rat | entinostat | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | entinostat results in increased expression of SLCO4C1 mRNA | CTD | PMID:26272509 | Slco4c1 | Rat | entinostat | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Slco4c1 | Rat | ethyl methanesulfonate | decreases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of SLCO4C1 mRNA | CTD | PMID:23649840 | Slco4c1 | Rat | folic acid | decreases expression | ISO | Slco4c1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of SLCO4C1 mRNA | CTD | PMID:25629700 | Slco4c1 | Rat | formaldehyde | decreases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of SLCO4C1 mRNA | CTD | PMID:23649840 | Slco4c1 | Rat | herbicide | multiple interactions | EXP | | 6480464 | [Phytochemicals co-treated with Environmental Pollutants co-treated with Food Preservatives co-treated with Plasticizers co-treated with Sunscreening more ... | CTD | PMID:25588985 | Slco4c1 | Rat | hexane | decreases methylation | EXP | | 6480464 | n-hexane results in decreased methylation of SLCO4C1 promoter | CTD | PMID:23740543 | Slco4c1 | Rat | isotretinoin | decreases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Isotretinoin results in decreased expression of SLCO4C1 mRNA | CTD | PMID:20436886 | Slco4c1 | Rat | L-homoarginine | increases export | ISO | SLCO4C1 (Homo sapiens) | 6480464 | SLCO4C1 protein results in increased export of Homoarginine | CTD | PMID:30865704 | Slco4c1 | Rat | lipopolysaccharide | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLCO4C1 mRNA | CTD | PMID:35811015 | Slco4c1 | Rat | lipopolysaccharide | decreases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of SLCO4C1 mRNA | CTD | PMID:35811015 | Slco4c1 | Rat | mercury dibromide | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Slco4c1 | Rat | mercury dichloride | decreases expression | EXP | | 6480464 | Mercuric Chloride results in decreased expression of SLCO4C1 mRNA | CTD | PMID:28536007 | Slco4c1 | Rat | mercury dichloride | decreases expression | ISO | Slco4c1 (Mus musculus) | 6480464 | Mercuric Chloride results in decreased expression of SLCO4C1 mRNA | CTD | PMID:27720909 | Slco4c1 | Rat | methamphetamine | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Methamphetamine results in increased expression of SLCO4C1 mRNA | CTD | PMID:25290377 | Slco4c1 | Rat | methylmercury chloride | decreases expression | ISO | Slco4c1 (Mus musculus) | 6480464 | methylmercuric chloride results in decreased expression of SLCO4C1 mRNA | CTD | PMID:27720909 | Slco4c1 | Rat | methylmercury chloride | decreases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of SLCO4C1 mRNA | CTD | PMID:28001369 | Slco4c1 | Rat | N(omega),N(omega)-dimethyl-L-arginine | increases uptake | ISO | SLCO4C1 (Homo sapiens) | 6480464 | SLCO4C1 protein results in increased uptake of N,N-dimethylarginine | CTD | PMID:30865704 | Slco4c1 | Rat | N-methyl-4-phenylpyridinium | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of SLCO4C1 mRNA | CTD | PMID:24810058 | Slco4c1 | Rat | nickel atom | decreases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Nickel results in decreased expression of SLCO4C1 mRNA | CTD | PMID:23195993|PMID:24768652 | Slco4c1 | Rat | nitrofen | increases expression | EXP | | 6480464 | nitrofen results in increased expression of SLCO4C1 mRNA | CTD | PMID:33484710 | Slco4c1 | Rat | ozone | multiple interactions | ISO | Slco4c1 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SLCO4C1 more ... | CTD | PMID:34911549 | Slco4c1 | Rat | p-chloromercuribenzoic acid | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in increased expression of SLCO4C1 mRNA | CTD | PMID:26272509 | Slco4c1 | Rat | p-chloromercuribenzoic acid | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Slco4c1 | Rat | panobinostat | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Slco4c1 | Rat | panobinostat | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | panobinostat results in increased expression of SLCO4C1 mRNA | CTD | PMID:26272509 | Slco4c1 | Rat | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of SLCO4C1 mRNA | CTD | PMID:32680482 | Slco4c1 | Rat | perfluorononanoic acid | decreases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of SLCO4C1 mRNA | CTD | PMID:32588087 | Slco4c1 | Rat | perfluorononanoic acid | multiple interactions | EXP | | 6480464 | [Phytochemicals co-treated with Environmental Pollutants co-treated with Food Preservatives co-treated with Plasticizers co-treated with Sunscreening more ... | CTD | PMID:25588985 | Slco4c1 | Rat | perfluorononanoic acid | decreases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of SLCO4C1 protein | CTD | PMID:25588985 | Slco4c1 | Rat | perfluorooctane-1-sulfonic acid | decreases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of SLCO4C1 mRNA | CTD | PMID:27153767 | Slco4c1 | Rat | phenylmercury acetate | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of SLCO4C1 mRNA | CTD | PMID:26272509 | Slco4c1 | Rat | phenylmercury acetate | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Slco4c1 | Rat | pioglitazone | multiple interactions | ISO | Slco4c1 (Mus musculus) | 6480464 | [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLCO4C1 mRNA | CTD | PMID:27935865 | Slco4c1 | Rat | potassium chromate | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of SLCO4C1 mRNA | CTD | PMID:22714537 | Slco4c1 | Rat | quercetin | decreases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of SLCO4C1 mRNA | CTD | PMID:21632981 | Slco4c1 | Rat | raloxifene | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of SLCO4C1 mRNA | CTD | PMID:19059307 | Slco4c1 | Rat | rifampicin | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Rifampin results in increased expression of SLCO4C1 mRNA | CTD | PMID:27199754 | Slco4c1 | Rat | ritonavir | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Ritonavir inhibits the reaction [SLCO4C1 protein affects the transport of traumatic acid] | CTD | PMID:39041788 | Slco4c1 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLCO4C1 mRNA | CTD | PMID:35811015 | Slco4c1 | Rat | SB 431542 | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Slco4c1 | Rat | silicon dioxide | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of SLCO4C1 mRNA | CTD | PMID:25895662 | Slco4c1 | Rat | sodium arsenite | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of SLCO4C1 mRNA | CTD | PMID:22714537 | Slco4c1 | Rat | sodium arsenite | decreases expression | ISO | Slco4c1 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of SLCO4C1 mRNA | CTD | PMID:37682722 | Slco4c1 | Rat | sulforaphane | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | sulforaphane results in increased expression of SLCO4C1 mRNA | CTD | PMID:26833863 | Slco4c1 | Rat | sunitinib | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of SLCO4C1 mRNA | CTD | PMID:31533062 | Slco4c1 | Rat | tamoxifen | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in increased expression of SLCO4C1 mRNA | CTD | PMID:19059307 | Slco4c1 | Rat | thalidomide | decreases expression | ISO | Slco4c1 (Mus musculus) | 6480464 | Thalidomide results in decreased expression of SLCO4C1 mRNA | CTD | PMID:26217789 | Slco4c1 | Rat | titanium dioxide | increases expression | ISO | Slco4c1 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of SLCO4C1 mRNA | CTD | PMID:23557971 | Slco4c1 | Rat | traumatic acid | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Ritonavir inhibits the reaction [SLCO4C1 protein affects the transport of traumatic acid] | CTD | PMID:39041788 | Slco4c1 | Rat | traumatic acid | affects transport | ISO | SLCO4C1 (Homo sapiens) | 6480464 | SLCO4C1 protein affects the transport of traumatic acid | CTD | PMID:39041788 | Slco4c1 | Rat | traumatic acid | affects transport | EXP | | 6480464 | SLCO4C1 protein affects the transport of traumatic acid | CTD | PMID:39041788 | Slco4c1 | Rat | trichostatin A | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of SLCO4C1 mRNA | CTD | PMID:24935251|PMID:26272509 | Slco4c1 | Rat | trichostatin A | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Slco4c1 | Rat | triphenyl phosphate | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | triphenyl phosphate results in increased expression of SLCO4C1 mRNA | CTD | PMID:28934090 | Slco4c1 | Rat | triphenyl phosphate | affects expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of SLCO4C1 mRNA | CTD | PMID:37042841 | Slco4c1 | Rat | valproic acid | affects expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SLCO4C1 mRNA | CTD | PMID:25979313 | Slco4c1 | Rat | valproic acid | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SLCO4C1 mRNA | CTD | PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369|PMID:29154799 | Slco4c1 | Rat | valproic acid | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Slco4c1 | Rat | vincristine | decreases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | Vincristine results in decreased expression of SLCO4C1 mRNA | CTD | PMID:23649840 | Slco4c1 | Rat | vorinostat | multiple interactions | ISO | SLCO4C1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Slco4c1 | Rat | vorinostat | increases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | vorinostat results in increased expression of SLCO4C1 mRNA | CTD | PMID:26272509 | Slco4c1 | Rat | zoledronic acid | decreases expression | ISO | SLCO4C1 (Homo sapiens) | 6480464 | zoledronic acid results in decreased expression of SLCO4C1 mRNA | CTD | PMID:24714768 | |






















